研究报告
梁冯,王泽夏,晏彪.NF-κB通路参与邻苯二甲酸二丁酯诱导U251细胞毒性的作用研究[J].环境科学学报,2019,39(2):640-648
NF-κB通路参与邻苯二甲酸二丁酯诱导U251细胞毒性的作用研究
- Role of the NF-κB pathway in dibutyl phthalate mediated effects in U251 cells
- 基金项目:湖北省卫生计生委面上项目(No.WJ2017M166);湖北省教育厅科学技术研究项目(No.B2018172)
- 王泽夏
- 湖北科技学院基础医学研究中心, 咸宁 437100
- 晏彪
- 湖北科技学院基础医学研究中心, 咸宁 437100
- 摘要:为探究nuclear factor-κB(NF-κB)通路及其分子事件相关蛋白参与邻苯二甲酸二丁酯(dibutyl-phthalate,DBP)诱导神经毒性的作用机制,以人胶质瘤细胞U251为对象,设置6个实验组:Control组,Tween 80组(阳性对照组)、25 μmol·L-1 DBP组、100 μmol·L-1 DBP组、20 μmol·L-1维生素E(vitamin E,VE)组、100 μmol·L-1 DBP+20 μmol·L-1 VE组.U251细胞经不同处理组分别暴露12 h及24 h后,观察细胞形态学结晶紫染色结果,检测细胞活性(CCK-8)、活性氧(reactive oxygen species,ROS)、丙二醛(malondialdehyde,MDA)、氧化应激转录因子NF-κB,以及NF-κB通路相关蛋白钙调神经磷酸酶(calcineurin,CaN)、泛素特异性蛋白酶14(ubiquitin-specific protease 14,USP14)、胶质细胞源性神经营养因子(glial cell line-derived neurotrophic factor,GDNF)的表达水平.与对照组相比,100 μmol·L-1 DBP组U251细胞的数量降低,细胞损伤,CCK-8降低,ROS、MDA含量显著升高,NF-κB水平显著升高,CaN、USP14表达均升高,GDNF表达降低,差异均有统计学意义(p<0.05,p<0.01);加入抗氧化剂VE处理后,与100 μmol·L-1 DBP组相比,100 μmol·L-1 DBP+20 μmol·L-1 M VE组U251细胞的数量增多,细胞损伤得到缓解,CCK-8上升,ROS、MDA含量显著降低,NF-κB水平显著降低,CaN、USP14表达均降低,GDNF表达增加,差异均有统计学意义(p<0.05,p<0.01).NF-κB和NF-κB通路相关蛋白的水平或含量变化表明,NF-κB作为氧化应激转录因子参与DBP诱导的U251细胞毒性作用;VE作为抗氧化剂可阻断ROS的生成从而抑制NF-κB的活化,提示VE在体外对DBP介导的神经毒性具有一定的保护作用.
- Abstract:To investigate the role of nuclear factor-κB (NF-κB) pathway and its related proteins involved in dibutyl-phthalate (DBP) induced neurotoxicity in U251 glioma cells. Six experimental groups were treated as follows:control group, Tween 80 group, 25 μmol·L-1 DBP group, 100 μmol·L-1 DBP, 20 μmol·L-1 vitamin E (VE), and 100 μmol·L-1 DBP combined with after-treatment of VE group. U251 cells were exposed to different treatment groups for 12 h and 24 h, respectively. The morphological changes of U251 cells were observed by crystal violet staining. The expression levels of CCK-8, reactive oxygen species (ROS), malondialdehyde (MDA), NF-κB (an oxidative stress transcription factor), calcineurin (CaN), ubiquitin-specific protease 14 (USP14) and glial cell line-derived neurotrophic factor (GDNF) were detected. Compared with the control group, the number of U251 cells in 100 μmol·L-1 DBP group was decreased, the contents of ROS and MDA were significantly increased (p<0.05, p<0.01), the expression of CaN and USP14 were significantly increased (p<0.05, p<0.01), and the expression of GDNF was decreased (p<0.05, p<0.01), respectively. After the antioxidant VE was added to the treatment, compared with the100 μmol·L-1 DBP group, the number of U251 cells in 100 μmol·L-1 DBP + 20 μmol·L-1 VE group was increased, the cell damage was alleviated, the content of ROS and MDA were significantly decreased (p<0.05, p<0.01), and the expression of CaN and USP14 were decreased significantly (p<0.05, p<0.01), and the expression of GDNF was increased (p<0.05, p<0.01). The changes of NF-κB and NF-κB pathway related proteins suggest that NF-κB, as an oxidative stress transcription factor, is associated with the cytotoxicity of U251 cells induced by DBP. And VE can inhibit the activation of NF-κB by blocking the production of ROS, suggesting that VE has a protective effect on neurotoxicity mediated by DBP in vitro.